General

Episode 17: Appen’s acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more!

Andrew Page

This week, we dissect Appen’s latest acquisition and touch on the ethics of AI.

We look to why shares in Envirosuite have surged higher, and ask whether the phenomenal gains from Clinuval Pharmaceuticals and Advance NanoTek can continue.

Plus Matt updates us on his recent meeting with the PushPay team.

For more great content, please visit us at www.strawman.com, www.mattjoass.com & www.ethicalequities.com.au

Email us at threewisemonkeyspodcast@gmail.com

And find us on Twitter @sage_simian @mattjoass @claudedwalker



Return to the Strawman Platform here

Strawman is Australia’s premier online investment club. Join for free to access independent & actionable recommendations from proven private investors.

Register for free ASX recommendations

This Service provides general financial advice only, and has not taken your personal circumstances into account. Strawman Pty Ltd operates under AFSL 501223 . For more information please see our Terms of use. Please remember that share market investments can go up and down and that past performance is not necessarily indicative of future returns. Strawman Pty Ltd does not guarantee the performance of, or returns on any investment.

© 2019 Strawman Pty Ltd. All rights reserved.

| Privacy Policy | Terms of Service |

ACN: 610 908 211 | Australian Financial Services Licence (AFSL): 501223



Related Articles

General

Computer Says No: a (mis)adventure In Property

Do you like highly illiquid assets that involve significant trade frictions and costs? Do you like dealing with an army of mostly useless, self-serving middlemen? Do you like assets that require extreme leverage and offer pitiful yields? Welcome to Australian property. I’m currently in the process of trying to secure a house, and I need to get a few things off […]

General

Strawman Investor Conference

The live Melbourne event was a lot of fun, giving us the chance to connect with over 50 of our members and share some interesting investment ideas. It was also great to put a face to a few familiar Strawman usernames. For those that couldn’t make it, you can check out a couple of the presentations on Youtube. Owen from […]

General

Are shares in AfterPay (ASX:APT) too expensive?

Following the completion of a hugely successful institutional capital raise — for which the business tapped the market for an extra $317.2 million — shares in payments disruptor AfterPay (ASX:APT) have surged back towards their recent record high. That takes gains for the past 12-months to a whopping 208%. There’s no doubt that things are going well for the business […]